Arbor, PI 48109.
The a b i 1 i t y of b a c t e r i a l r e s t r i c t i o n endonuclease t o recoaniz s p e c i f i c senuences i n DNA makes them a p o t e n t t o o l f o r d i s s e c t i o o f t h e human nenome. The o r o a n i z a t i o n o f ribosomal nenes i n normal and n e o~l a s t i c human t i s s u e s has been s t u d i e d by t h e r e s t r i c t i o n o f n u r i f i e d DNA. Franments o f CNA produced bv the r e s t r i c t i o n endonucleases EcoRI and H i n d I I I were senarated accordinn t o s i z e bv anarose n e l e l e c t r o n h o r e s i s . DNA franments w h i~$~c o n t a i n e d ribosomal oenes were i d e n t i f i e d by h y b r i d i z a t i o n t o
I -l a b e l l e d human ribosomal RNP and autoradiopraohy. A n a l v s i s o f these s t u d i e s showed t h a t EcoRI cleaves ribosomal ON from human spleen i n t o f r a a e n t s o f t h r e e s i z e s (molecular 8' weiqhts 12, 5, and 4.2 x 10 ) . D i o e s t i o n w i t h H i n d I I I y i e l d s fraaments of two s i z e s (molecular weiohts 9.3, and 8.A x 106). These d a t a o e r m i t t h e c o n s t r u c t i o n o f a s i n n l e map f o r t h e human ribosomal qene of 17 x 106 d a l t o n s . A s i m i l a r a n a l v s i s o f human DNA from several f i b r o b l a s t and tumor c e l l l i n e s shows v a r i a t i o n o n l v a t a s i n o l e EcoRI s i t e .
Desnite marked a l t e r a t i o n s i n karyotvpe, t h e o r o a n i z a t i o n of ribosomal oenes has been s t r o n n l v conserved i n t h e n e o p l a s t i c t i s s u e s so f a r examined. 
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A one year old North American Indian boy who presented with episodes of vomiting, lethargy and periodic hypoglycaemia was shown to have hereditary fructose intolerance. A liver biopsy showed typical histological changes and fructose-I-phosphate aldolase activity was greatly diminished.
Although blood fructose increased only slightly during an ora fructose tolerance test, he developed severe hypoglycaemia which did not respond to glucagon. Insulin levels remained low. Plasma lactic acid, uric acid, magnesium, methionine, valine, leucine, isoleucine and aspartate aminotransferase rose during the test while potassium and phosphate fell markedly. Continuous f E G monitoring showed no significant changes, but an ECG showed a slight cardiac arrhythmia when potassium was at its lowest level. Urinary excretion of uric acid and magnesium increased during the fructose load, but there was no. rise in the excretion of potassium, phosphate, or bicarbonate.
Patients with hereditary fructose intolerance may exhibit a Fdnconisyndrme and this has been blamed for the falling plasma potassium during a fructose load. The hypokalemic response to acute fructose loading in this patient has been demonstrated not to be due to renal losses. We speculate that potassium probably entered the intracellular space when fructose was administered. We have used glycine for the acute and chronic management of two newborn infants with isovaleric acidemia. Both infants presented with deep coma and serum isovaleric acid levels in excess of 50 mg/dl after several days of treatment with parenteral fluids and protein restriction. After administration of intravenous glycine (250 rnglkglday) the serum isovaleric acid level declined to less than 1 mg/dl within 3 days. Restoration of normal clinical status occurred within 6 days. Unexpectedly, the sharp decline of the serum isovaleric acid level was not accompanied by an equally sharp rise of urinary isovalerylglycine excretion. This suggests that in neonates isovalerylglycine may be excreted by the GI tract or that the glycine effect is mediated through a mechanism other than the synthesis of isovalerylglycine. The infants have been treated prophylactically with a low protein diet and oral glycine for 3 and 8 months, respectively. Their psychomotor development has been entirely normal. Neither has suffered a relapse even though the older infant has had several intercurrent infections. Glycine treatment in neonates appears to have aided in the management of the acute toxicity of isovaleric acidemia and may have prevented the reaccumulation of isovaleric acid.
575
HEMATOLOGY AND ONCOLOGY
I HETEROZYGOTE EXPRESSION I N PROPIONYL CoA CARBOXYLASE (PCC) DEFICIENCY: DIFFERENCES BETWEEN THE MAJOR COM-I
PLEMENTATION GROUPS. B a r r y Wolf and Leon E. ~o s e n b e r h Dept. Hum. Gen. and Peds., Yale Univ. Sch. Med.. New Haven. CT
I PCC d e f i c i e n c y , an autosomal r e c e s s i v e l y i n h e r i t e d d i s o r d e r , c o n s t i t u t e s a t l e a s t two major g e n e t i c complementation groups (A and C) each c h a r a c t e r i z e d by t h e presence o f s t r u c t u r a l l y a l t e r e d PCC. We now r e p o r t s t u d i e s o f PCC a c t i v i t y i n t i s s u e e x t r a c t s from c o n t r o l s and o b l i g a t e heterozygotes from b o t h complementatiol groups. PCC a c t i v i t y i n f i b r o b l a s t e x t r a c t s from 6 group
A h e terozygotes was 43-64% o f t h a t i n c o n t r o l e x t r a c t s (p<0.001), w h i l e a c t i v i t y i n 12 group C heterozygotes was i n d i s t i n g u i s h a b l e f r o m c o n t r o l values. S i m i l a r r e s u l t s were obtained u s i n g periphe r a l blood leukocytes. I n none o f 8 f a m i l i e s ( 5 group C; 3 group A) i n which PCC a c t i v i t y was s t u d i e d i n b o t h parents o f an a f f e c t . ed c h i l d were s i g n i f i c a n t d i f f e r e n c e s observed between parents. T h e r m o s t a b i l i t y (45'C) o f PCC a c t i v i t y i n heterozygotes from b o t h groups was i d e n t i c a l t o c o n t r o l . A c t i v i t i e s o f two o t h e r m i t oc h o n d r i a l enzymes (6-methylcrotonyl CoA carboxylase and glutamdte dehydrogenase) were comparable i n c o n t r o l s and b o t h groups of ieterozygotes. Whereas t h e data from group A heterozygotes conforms t o expected gene-dose e f f e c t s , t h e r e s u l t s from group C leterozygotes a r e d i s t i n c t l y unusual. Since mammalian PCC i s a tetramer, t h e l a t t e r r e s u l t s may r e f l e c t any o f t h e f o l l o w i n g nechanisms: normal PCC a c t i v i t y i n tetramers w i t h a t l e a s t one iormal subunit; an increased p r o p o r t i o n o f normal subunits due t o increased degradation of mutant subunits; o r compensatory synthes i s o f normal subunits. Urinary iron excretions with DF and vit. C were evaluated over 48-hour periods in an iron overloaded 9-year-old male with congenital hypoplastic anemia. SQ DF was 85% as effective as I.V. DF. A 12-hour SQ infusion produced the highest excretion during treatment but had a significant effect for 36 hours. Dose response curves were determined for each drug with continuous 12-hour SQ infusions. Using a constant vit. C dose of 500 mg p.o./d and increasing doses of DF, 36 hr. urinary iron increased from 22.5 mg with 1 gm DF to 56.2 mg with 4 gm DF (linear correlation coefficient 0.96, p <0.01). Increasing doses of vit. C (0.5 to 3 p/d) with a constant DF dose of 2.9 gm were not associated with significant increases in iron excretion (from 44.2 to 49.9 mg) (linear correlation coefficient 0.66, p >0.05).
Continuous EKG and frequent echocardiogram monitoring showed no arrythmias or other changes in cardiac function with doses up to 3 gm vit. C. Our data shows that increased iron excretion continues for 36 hours following 12-hour SQ infusions of DF. A linear increase in excretion occurred with SQ DF doses up to 4 gm. Raising the vit. C dose from 0.5 to 3 gm per day did not result in a significant increase in iron excretion.
